This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune device, a specialized cancer therapy technology utilizing Tumor Treating Fields (TTFields). The contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), has a ceiling value of $49,748.73 and is structured as a firm fixed-price purchase order with a completion date of July 16, 2025. Novocure holds a significant...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune system, a cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 (VISN 12) for the delivery of Optune medical devices, transducer arrays, rental...
This federal contract award is for the provision of Novocure Inc.'s Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $45,600.00 firm fixed-price Purchase Order was awarded to the prime contractor Novocure Inc., a foreign-owned, for-profit medical device manufacturer, on August 27, 2024, with a completion date of January 13,...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the provision of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. This contract does not utilize a set-aside designation, likely due to the...
This federal contract award is for Novocure Inc., a foreign-owned, for-profit medical device manufacturer, to provide the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with its Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract, valued at $16,582.91, is a firm fixed-price delivery order awarded under Novocure's $28.85 million Federal Supply Schedule...
This federal contract award to Novocure Inc. is for the procurement of the company's Optune Plus Transducers product line, a cancer therapy device that delivers Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price contract was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and is not set aside. Novocure, a foreign-owned for-profit manufacturer, holds a 5-year Federal Supply Schedule (FSS) contract...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract (Award ID: 36C26223P0309), with a ceiling value of $16,582.91, is a Firm Fixed Price Purchase Order placed under...
This federal contract award is for the provision of Novocure Inc.'s Optune tumor treating fields (TTFields) therapy devices, transducers, rentals, and support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is a firm fixed price purchase order with a potential value of $105,000.00. Novocure, a foreign-owned, for-profit medical technology company, is the prime contractor for this order, which does not have a set-aside designation. The...
This federal contract award to Novocure Inc., a foreign-owned medical device manufacturer, is for the provision of the Optune Plus Transducers system, a non-invasive cancer treatment technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The $49,748.73 firm fixed-price contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Novocure as the prime contractor. The award does not...